| Anticancer Fund

Discover our Annual Report 2020

Mon, 02/15/2021 - 12:00

World Cancer Day - Because every patient deserves optimal treatment

Thu, 02/04/2021 - 12:00

The Anticancer Fund supports EORTC trial in oligometastatic rare cancers with Rising Tide Foundation

Tue, 02/02/2021 - 12:00

First patient in EORTC's trial for retroperitoneal sarcoma

Thu, 01/21/2021 - 12:00

Study in pancreatic cancer improved survival rate of mice

Fri, 01/08/2021 - 12:00

A publication by scientists of the Anticancer Fund

Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study

Christoffer Gebhardt, Sonja C S Simon, Rebekka Weber, Mirko Gries, Dong Hun Mun, Raphael Reinhard, Tim Holland-Letz, Viktor Umansky, Jochen Utikal. Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study. Cellular Immunology, 2021 Feb;360:104274, doi: 10.1016/j.cellimm.2020.104274

Mon, 12/28/2020 - 12:00

The MATAO trial for ovarian cancer patients is open for participation

Fri, 12/11/2020 - 12:00

Discovering Darwin in oncology: Launch of a ‘Request for Application’ for researchers in evolutionary therapy

Tue, 12/01/2020 - 12:00